Vizora日本語

Astellas×Daiichi Sankyo

Different ways of making money, on the same scale.

Same yardstick

MetricAstellasFY ending Mar 2024Daiichi SankyoFY ending Mar 2024
Revenue¥1.6T¥1.6T
COGS ratio——
Operating margin——
Net margin1.1%12.5%
FCF margin——

Highlighted = best value for that metric

Compare industry percentiles by axis

Each row uses the same 0–100 scale. Dots show each company's rank within its primary industry.

  • AstellasPrimary industry: Pharmaceuticals
  • Daiichi SankyoPrimary industry: Pharmaceuticals
CompanyRank

  • Revenue growth

    • AstellasN/A
    • Daiichi SankyoN/A

  • Profitability

    • AstellasN/A
    • Daiichi SankyoN/A

  • Cash conversion

    • AstellasN/A
    • Daiichi SankyoN/A

  • Efficiency

    • Astellas39.132 peers
    • Daiichi Sankyo42.232 peers

  • Financial strength

    • AstellasN/A
    • Daiichi SankyoN/A

Each dot is a company's percentile within its primary industry; peer groups may differ. Missing axes are labeled as unavailable. No combined score is calculated, and industry rank is not an investment recommendation.

Money flows side by side

Chart height is proportional to revenue.

Astellas¥1.6T

※ Cost of revenue is not disclosed; expenses are combined

※ Operating income is not disclosed; the chart goes straight to pretax income including investment gains

Daiichi Sankyo¥1.6T

※ Cost of revenue is not disclosed; expenses are combined

※ Operating income is not disclosed; the chart goes straight to pretax income including investment gains

Analyze this page with AI

Markdown with figures, units, periods and sources, ready to paste into ChatGPT or Claude.

Open Markdown